Vincenzo S. Gilberto

Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy

Devin Wahl, Sydney Risen, Shelby C. Osburn et al. · Journal of Neuroinflammation · 2024 · 23 citations · Full text

Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders

Sydney Risen, Sean W. Boland, Sadhana Sharma et al. · ACS Chemical Neuroscience · 2024 · 20 citations

Neurochemical Biomarkers, Pharmacologic Downregulation, Therapeutics +22

Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease

Arielle Hay, Amanda S. Latham, Genova Mumford et al. · Frontiers in Neuroscience · 2023 · 19 citations · Full text

Creutzfeldt-jakob Disease, Immunology, Cell Death +23

Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs

Sydney Risen, Sadhana Sharma, Vincenzo S. Gilberto et al. · ACS Pharmacology & Translational Science · 2024 · 11 citations · Full text

Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model

Sadhana Sharma, Sydney Risen, Vincenzo S. Gilberto et al. · ACS Chemical Neuroscience · 2024 · 10 citations